JLE

Epileptic Disorders

MENU

Generic substitutions of antiseizure medications: recommendations issued by the Israeli Chapter of the International League Against Epilepsy Volume 24, numéro 5, October 2022

Tableaux

Auteurs
1 Epilepsy and EEG Unit, Neurology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
2 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
3 Pediatric Epilepsy and Neurology Service, Barzilai Medical Center, Ashkelon, Israel
4 Department of Neurology, Rambam Health Care Center, Haifa, Israel
5 Faculty of Medicine, Technion, Institute of Technology, Haifa, Israel
6 Pediatric Neurology Unit, Soroka University Medical Center, Israel
7 Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel
8 Department of Neurology, Agnes Ginges Center of Human Neurogenetics, Hadassah Medical Organization, Jerusalem, Israel
9 Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel
10 Pediatric Neurology Unit, Safra Pediatric Hospital, Sheba Medical Center, Tel Hashomer, Israel
11 Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel
Correspondence:
Sara Eyal
Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Ein Kerem, Jerusalem, 91120, Israel

ILAE Academy

Licence Cette œuvre est mise à disposition selon les termes de la Licence Creative Commons Attribution - ShareAlike 3.0 International